Anzeige
Meldung des Tages: HydroGraph stieg von 0,20 auf 11,30 – ist diese Graphen-Aktie bei 0,37 als Nächste dran?!

PTC Therapeutics News

Aktie
WKN:  A1W0MW ISIN:  US69366J2006 US-Symbol:  PTCT Branche:  Biotechnologie Land:  USA
68,20 $
-0,39 $
-0,57%
58,199 € 24.04.26
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
-
KGV
8,64
Index-Zuordnung
-

PTC Therapeutics News

22.04.26 - PR Newswire
PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026
PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026 PR Newswire
17.04.26 - PR Newswire
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
25.03.26 - PR Newswire
PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors
PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors PR Newswire
18.03.26 - dpa-AFX
Karlsruhe entscheidet zu Kostenübernahme für Medikament
Das Bundesverfassungsgericht will am Mittwoch (9.30 Uhr) seine Entscheidung zu einem Rechtsstreit um die Kostenübernahme für Medikamente bei tödlichen Erkrankungen ...
13.03.26 - PR Newswire
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
23.02.26 - PR Newswire
PTC Therapeutics to Participate at Upcoming Investor Conferences
PTC Therapeutics to Participate at Upcoming Investor Conferences PR Newswire
19.02.26 - PR Newswire
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results PR Newswire
12.02.26 - PR Newswire
PTC Therapeutics Provides Regulatory Update on Translarna™
PTC Therapeutics Provides Regulatory Update on Translarna™ PR Newswire
05.02.26 - PR Newswire
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 PR Newswire
12.01.26 - PR Newswire
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference
PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference PR Newswire
08.01.26 - PR Newswire
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
22.12.25 - PR Newswire
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan
PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan PR Newswire
19.12.25 - PR Newswire
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
18.12.25 - PR Newswire
PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
01.12.25 - PR Newswire
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
20.11.25 - PR Newswire
PTC Therapeutics to Host R&D Day
PTC Therapeutics to Host R&D Day PR Newswire
04.11.25 - PR Newswire
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results PR Newswire
31.10.25 - PR Newswire
PTC Therapeutics to Participate at Upcoming Investor Conferences
PTC Therapeutics to Participate at Upcoming Investor Conferences PR Newswire
27.10.25 - PR Newswire
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire
21.10.25 - PR Newswire
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results
PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2025 Financial Results PR Newswire

Newssuche

Videos

newspaper
20.04.26 +3,54%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »